ANI Pharmaceuticals Inc (ANIP): Revenue
$883.37M
Year ended 2025-12-31
$978.38M
Trailing 12 months to 2026-06-30
+40.8%
3-year compound annual growth
+33.5%
5-year compound annual growth
+27.7%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $883.37M | +43.8% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $614.38M | +26.2% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $486.82M | +53.9% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $316.38M | +46.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $216.14M | +3.7% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $208.47M | +0.9% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $206.55M | +2.5% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $201.58M | +14.0% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $176.84M | +37.5% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $128.62M | +68.5% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $76.32M | +36.4% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $55.97M | +86.1% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $30.08M | +47.7% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $20.37M | n/m | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | $435.2K | -82.4% | 2013-02-28, From 2011-01-01 |
| 2010-12-31 | $2.47M | +96.7% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $1.26M | n/a | 2012-03-13, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $883.37M | +43.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $868.45M | +21.5% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $829.45M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $943.71M | +33.8% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $780.57M | +23.6% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $761.41M | +12.8% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $742.90M | -28.8% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗